Sangamo Therapeutics Inc (NASDAQ:SGMO) has been in a consolidation phase in the past two sessions and if the stock is able to move past the strong resistance of 18.64 with good volumes, then it will mean higher levels for the stock. The relative strength line is exhibiting a small negative divergence, which is usually a bearish sign, but in this particular case could be considered a typical move after a huge rally. The MACD indicator for the stock is still above its trigger line. A bullish breakout abv 18.64 would imply a continuation of the recent upbeat momentum, with $20 the pattern target on the buyers’ radar.